HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tadao Akizawa Selected Research

Darbepoetin alfa (Aranesp)

10/2021Factors affecting the doses of roxadustat vs darbepoetin alfa for anemia treatment in hemodialysis patients.
2/2021Initial responsiveness to darbepoetin alfa and its contributing factors in non-dialysis chronic kidney disease patients in Japan.
1/2021Factors Affecting Doses of Roxadustat Versus Darbepoetin Alfa for Anemia in Nondialysis Patients.
1/2020Phase 3, Randomized, Double-Blind, Active-Comparator (Darbepoetin Alfa) Study of Oral Roxadustat in CKD Patients with Anemia on Hemodialysis in Japan.
1/2020Darbepoetin Alfa in Patients with Advanced CKD without Diabetes: Randomized, Controlled Trial.
1/2020Efficacy and Safety of Daprodustat Compared with Darbepoetin Alfa in Japanese Hemodialysis Patients with Anemia: A Randomized, Double-Blind, Phase 3 Trial.
2/2019Safety and effectiveness of long-term use of darbepoetin alfa in non-dialysis patients with chronic kidney disease: a post-marketing surveillance study in Japan.
1/2019Correction to: Safety and effectiveness of long-term use of darbepoetin alfa in non-dialysis patients with chronic kidney disease: a post-marketing surveillance study in Japan.
2/2018Rationale and design of oBservational clinical Research In chronic kidney disease patients with renal anemia: renal proGnosis in patients with Hyporesponsive anemia To Erythropoiesis-stimulating agents, darbepoetiN alfa (BRIGHTEN Trial).
1/2018Erratum to: Rationale and design of oBservational clinical Research In chronic kidney disease patients with renal anemia: renal proGnosis in patients with Hyporesponsive anemia To Erythropoiesis-stimulating agents, darbepoetiN alfa (BRIGHTEN Trial).
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tadao Akizawa Research Topics

Disease

83Chronic Renal Insufficiency
12/2022 - 10/2004
74Secondary Hyperparathyroidism
06/2022 - 01/2002
63Anemia
12/2022 - 04/2003
30Hypoxia (Hypoxemia)
09/2022 - 01/2017
29Chronic Kidney Failure (Chronic Renal Failure)
01/2021 - 01/2002
19Cardiovascular Diseases (Cardiovascular Disease)
01/2019 - 01/2005
18Hyperphosphatemia
07/2022 - 03/2003
14Kidney Diseases (Kidney Disease)
01/2017 - 11/2003
10Proteinuria
02/2021 - 01/2007
10Inflammation (Inflammations)
01/2021 - 01/2009
10Glomerulonephritis
01/2019 - 03/2003
8Drug-Related Side Effects and Adverse Reactions
01/2022 - 01/2019
8Diabetic Nephropathies (Diabetic Nephropathy)
06/2020 - 03/2003
7Uremia
01/2021 - 09/2003
7Hypercalcemia (Milk Alkali Syndrome)
01/2018 - 06/2002
7Hyperplasia
08/2008 - 06/2003
6Chronic Kidney Disease-Mineral and Bone Disorder (Renal Rickets)
11/2019 - 03/2003
6Renal Insufficiency (Renal Failure)
08/2011 - 09/2005
5Weight Gain
07/2021 - 01/2011
5Vascular Calcification
01/2021 - 01/2008
5Type 2 Diabetes Mellitus (MODY)
06/2020 - 11/2010
5Bone Diseases (Bone Disease)
01/2018 - 03/2005
5Hypertension (High Blood Pressure)
04/2014 - 04/2003
4Neoplasms (Cancer)
12/2022 - 01/2010
4Diabetes Mellitus
09/2022 - 01/2012
4Vomiting
01/2021 - 01/2017
4Atherosclerosis
01/2011 - 12/2004
4Disease Progression
11/2010 - 12/2002
3Diarrhea
02/2022 - 01/2021
3Nausea
01/2021 - 06/2004
3Peripheral Arterial Disease
01/2021 - 12/2002
3Heart Failure
06/2020 - 01/2012
3Infections
01/2019 - 08/2010
3Stroke (Strokes)
12/2016 - 10/2007
3Pruritus (Itching)
07/2014 - 12/2004
3Acidosis
04/2014 - 12/2013
3Hyperlipidemias (Hyperlipidemia)
09/2008 - 06/2004
2COVID-19
05/2022 - 01/2021
2Retinal Hemorrhage
04/2022 - 01/2020
2Hypocalcemia
01/2022 - 03/2003
2Iron Deficiencies
01/2021 - 01/2002

Drug/Important Bio-Agent (IBA)

29CalciumIBA
02/2022 - 03/2003
27Prolyl-Hydroxylase InhibitorsIBA
09/2022 - 01/2017
27Hemoglobins (Hemoglobin)IBA
09/2022 - 03/2009
27Parathyroid Hormone (Parathormone)IBA
06/2022 - 01/2002
26HematinicsIBA
12/2021 - 06/2010
20ErythropoietinFDA Link
08/2022 - 01/2002
20Phosphates (Orthophosphate)IBA
02/2022 - 02/2005
18Phosphorus (Red Phosphorus)IBA
02/2022 - 03/2003
18Cinacalcet (Sensipar)FDA Link
01/2022 - 06/2004
18MineralsIBA
10/2020 - 03/2005
16Darbepoetin alfa (Aranesp)FDA Link
10/2021 - 02/2008
16Vitamin DFDA LinkGeneric
01/2016 - 12/2002
13IronIBA
08/2022 - 06/2010
13evocalcetIBA
01/2022 - 01/2018
10roxadustatIBA
09/2022 - 01/2019
10molidustatIBA
04/2022 - 01/2019
10maxacalcitolIBA
03/2017 - 06/2002
10CreatinineIBA
04/2014 - 06/2004
9Calcitriol Receptors (Calcitriol Receptor)IBA
01/2022 - 01/2005
7Pharmaceutical PreparationsIBA
02/2022 - 02/2005
7Serum AlbuminIBA
02/2019 - 01/2008
6enarodustatIBA
08/2022 - 01/2019
6etelcalcetide hydrochlorideIBA
01/2021 - 01/2017
6bixalomerIBA
04/2017 - 12/2013
6Calcitriol (Calcijex)FDA LinkGeneric
03/2017 - 06/2003
6AST 120IBA
11/2010 - 03/2003
5GSK1278863IBA
12/2022 - 01/2017
5Ferritins (Ferritin)IBA
01/2021 - 01/2002
5Therapeutic UsesIBA
01/2021 - 05/2009
5Calcium-Sensing ReceptorsIBA
01/2018 - 10/2004
5Sevelamer (RenaGel)FDA Link
01/2018 - 10/2003
5Proteins (Proteins, Gene)FDA Link
06/2015 - 03/2003
5Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
01/2015 - 09/2005
4tenapanorIBA
07/2022 - 01/2021
4bardoxolone methylIBA
06/2020 - 01/2013
4C-Reactive ProteinIBA
05/2020 - 01/2015
4AlbuminsIBA
01/2019 - 07/2004
4Biomarkers (Surrogate Marker)IBA
06/2018 - 06/2010
4Ethanol (Ethyl Alcohol)IBA
08/2008 - 12/2002
3Fibroblast Growth Factor-23IBA
01/2022 - 06/2010
3Calcium Carbonate (Limestone)FDA Link
01/2021 - 03/2006
3Prolyl Hydroxylases (Prolyl Hydroxylase)IBA
01/2021 - 11/2018
3Dialysis SolutionsIBA
08/2020 - 01/2009
3Antihypertensive Agents (Antihypertensives)IBA
07/2014 - 09/2005
3Imatinib Mesylate (Gleevec)FDA Link
03/2013 - 05/2009
3LipidsIBA
06/2010 - 08/2007
3Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
12/2009 - 10/2008
3SterolsIBA
10/2008 - 06/2004
2SodiumIBA
06/2022 - 09/2008
2upacicalcetIBA
06/2022 - 01/2022
2calcium phosphateIBA
11/2021 - 07/2009
2Transferrin (beta 2 Transferrin)IBA
01/2021 - 07/2004
2Alkaline PhosphataseIBA
01/2021 - 01/2009
2lanthanum carbonate (Fosrenol)FDA Link
01/2021 - 02/2014

Therapy/Procedure

108Renal Dialysis (Hemodialysis)
07/2022 - 04/2002
46Therapeutics
01/2021 - 03/2003
7Peritoneal Dialysis
04/2022 - 02/2008
5Catheters
02/2011 - 01/2003
3Parathyroidectomy
01/2019 - 08/2008